Type |
Details |
Score |
Allele |
Name: |
CD84 antigen; endonuclease-mediated mutation 1, Cyagen Biosciences |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; endonuclease-mediated mutation 2, Cyagen Biosciences |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; endonuclease-mediated mutation 3, Cyagen Biosciences |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; targeted mutation 1, Pamela L Schwartzberg |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; targeted mutation 1a, Mouse Biology Program, UC Davis |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; targeted mutation 1e, Mouse Biology Program, UC Davis |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; targeted mutation 1b, Mouse Biology Program, UC Davis |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; endonuclease-mediated mutation 2, GemPharmatech Co., Ltd |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Allele |
Name: |
CD84 antigen; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd84/Cd84 |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
329
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
140
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
328
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd84/Cd84 |
Background: |
C57BL/6J-Cd84 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd84/Cd84 |
Background: |
B6N(Cg)-Cd84/J |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd84/Cd84 Tg(TcraTcrb)425Cbn/? |
Background: |
B6.Cg-Cd84 Tg(TcraTcrb)425Cbn |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd84/Cd84<+> |
Background: |
B6N(Cg)-Cd84/J |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Calì B |
Year: |
2024 |
Journal: |
Cancer Cell |
Title: |
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer. |
Volume: |
42 |
Issue: |
10 |
Pages: |
1676-1692.e11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sayos J |
Year: |
1998 |
Journal: |
Nature |
Title: |
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. |
Volume: |
395 |
Issue: |
6701 |
Pages: |
462-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morra M |
Year: |
2001 |
Journal: |
EMBO J |
Title: |
Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. |
Volume: |
20 |
Issue: |
21 |
Pages: |
5840-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cannons JL |
Year: |
2011 |
Journal: |
Annu Rev Immunol |
Title: |
SLAM family receptors and SAP adaptors in immunity. |
Volume: |
29 |
|
Pages: |
665-705 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hwang PM |
Year: |
2002 |
Journal: |
EMBO J |
Title: |
A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome. |
Volume: |
21 |
Issue: |
3 |
Pages: |
314-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Poy F |
Year: |
1999 |
Journal: |
Mol Cell |
Title: |
Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. |
Volume: |
4 |
Issue: |
4 |
Pages: |
555-61 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH2 domain of EAT-2 (EWS-Fli1-activated transcript-2) and ERT (EAT-2-related transducer).The X-linked lymphoproliferative syndrome (XLP) gene encodes SAP (also called SH2D1A/DSHP) a protein that consists of a 5 residue N terminus, a single SH2 domain, and a short 25 residue C-terminal tail []. XLP is characterized by an extreme sensitivity to Epstein-Barr virus. Both T and natural killer (NK) cell dysfunctions have been seen in XLP patients. SAP binds the cytoplasmic tail of Signaling lymphocytic activation molecule (SLAM), 2B4, Ly-9, and CD84 []. SAP is believed to function as a signaling inhibitor, by blocking or regulating binding of other signaling proteins. SAP and the SAP-like protein EAT-2 recognize the sequence motif TIpYXX[VI], which is found in the cytoplasmic domains of a restricted number of T, B, and NK cell surface receptors and are proposed to be natural inhibitors or regulators of the physiological role of a small family of receptors on the surface of these cells [, ]. EAT-2 (also known as SH2 domain-containing protein 1B or SH2D1B) and ERT (also known as SH2 domain-containing protein 1C or SH2D1C), similar to SAP, are composed of a single SH2 domain and a short C terminus. They share approximately 50% amino acid identity with SAP []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Tovar V |
Year: |
2002 |
Journal: |
Immunogenetics |
Title: |
Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors. |
Volume: |
54 |
Issue: |
6 |
Pages: |
394-402 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burbage M |
Year: |
2018 |
Journal: |
Elife |
Title: |
Tuning of in vivo cognate B-T cell interactions by Intersectin 2 is required for effective anti-viral B cell immunity. |
Volume: |
7 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Jabba SV |
Year: |
2006 |
Journal: |
BMC Med |
Title: |
Macrophage invasion contributes to degeneration of stria vascularis in Pendred syndrome mouse model. |
Volume: |
4 |
|
Pages: |
37 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
132
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
132
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
132
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
132
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
57
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
132
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Gerhard DS |
Year: |
2004 |
Journal: |
Genome Res |
Title: |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
Volume: |
14 |
Issue: |
10B |
Pages: |
2121-7 |
|
•
•
•
•
•
|